13 minutes ago
Key FDA approvals, clinical trial insights, and expert commentary in allergy care from the first half of 2025.
5 hours ago
The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.
July 04, 2025
Our recap of Q2 2025 in cardiology spotlights 3 FDA headlines, trial news, and new episodes of Don't Miss a Beat.
July 04, 2025
Q2 2025 saw new therapies approved for rare rheumatological conditions and exciting research out of EULAR.
July 04, 2025
According to recent research, more patients surviving heart diseases correlates directly to higher mortality rates for ischemic and chronic heart conditions.